Statistics
Publications
60
Citations
4.8K
H-Index
29
Active since
1983
Michel Delforge is an author at Universitair Ziekenhuis Leuven specializing in medicine, oncology, and multiple myeloma.
Publications per year
1983–2024
60
60
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text
Medicine, Hematology, Immunology +17
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text
María‐Victoria Mateos, Katja Weisel, Valerio De Stefano et al. · Leukemia · 2022 · 240 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Peter Vandenberghe, Iwona Włodarska, Thomas Tousseyn et al. · The Lancet Haematology · 2015 · 146 citations
1–5 of 60